Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?

Author: Riese David J  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.6, Iss.2, 2011-02, pp. : 185-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract